19-5994921-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000635.4(RFX2):c.2086G>A(p.Glu696Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000591 in 1,608,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000635.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152194Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000823 AC: 20AN: 243088Hom.: 0 AF XY: 0.0000528 AC XY: 7AN XY: 132470
GnomAD4 exome AF: 0.0000405 AC: 59AN: 1456058Hom.: 0 Cov.: 31 AF XY: 0.0000414 AC XY: 30AN XY: 724726
GnomAD4 genome AF: 0.000236 AC: 36AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2086G>A (p.E696K) alteration is located in exon 18 (coding exon 17) of the RFX2 gene. This alteration results from a G to A substitution at nucleotide position 2086, causing the glutamic acid (E) at amino acid position 696 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at